BEMNET ZELEKE: Open Payments
NPI 1356614655 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 19 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $142 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $185 |
| Lilly USA, LLC | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Novo Nordisk Inc | 1 | $29 |
| Amgen Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: RINVOQ, MOUNJARO, SKYRIZI, Rybelsus, KRYSTEXXA, UBRELVY, ZEPBOUND, JARDIANCE.
Industry payments across MD — which companies pay providers there.
